Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    19564349 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)
Conditions: Melanoma;   Squamous Cell Carcinoma of the Head and Neck;   Squamous Cell Carcinoma of the Skin;   Sarcoma of the Skin;   Basal Cell Cancer of the Skin;   Breast Cancer
Intervention: Drug: Poly-ICLC
2 Recruiting Enhancement by Poly-ICLC During HIV-1 Infection
Condition: HIV-1 Infected Adults With Chronic HIV-1 Infection
Interventions: Drug: Arm A: Poly-ICLC;   Drug: Arm B: Normal Saline

Indicates status has not been verified in more than two years